Established in 2025, RBM Pharma is a dynamic Trader and Supplier of pharmaceutical products headquartered in Surat, Gujarat, India. With a focus on precision-driven and research-backed formulations, the company specializes in a carefully curated range of medicines including bevacizumab injections, carboplatin injection IP, eribulin injection, acalabrutinib tablets, gefitinib tablets IP, somatropin 36IU injection, eltrombopag tablets, semaglutide tablets, and albendazole tablets IP.
We believes in delivering uncompromised pharmaceutical excellence. Every product reflects a promise of high purity, enhanced absorption, and optimized shelf life. Complying with global standards and manufactured using certified technologies, the offerings are designed to meet both domestic and international quality expectations. A streamlined supply model ensures that quality medicines reach clients with speed and reliability. Through its deep understanding of healthcare needs and a client-focused approach, our company continues to build a trusted network across the pharmaceutical industry.
Key Facts of RBM Pharma:
Nature
of Business
|
Trader,
Supplier
|
Location
|
Surat,
Gujarat, India
|
Year
Of Establishment
|
2025
|
GST
Number
|
24HITPM5876G1ZG
|
No.
of Employees
|
01
|
IE
Code
|
HITPM5876G
|
Export
Percentage
|
100%
|
|
|
|
|